Providence, RI, United States of America

Steven C Katz

This inventor holds 2 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Prospect Charactercare Rwmc, LLC, Prospect Chartercare Rwmc, LLC. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven C Katz. Retrieved from https://idiyas.com/inventor/steven-c-katz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Steven C Katz

Introduction

Steven C Katz is a notable inventor based in Providence, RI (US). He has made significant contributions to the field of medical technology, particularly in the treatment of cancers. With a total of 2 patents, his work focuses on innovative methods for targeting and treating tumors.

Latest Patents

One of his latest patents is titled "Hepatic arterial infusion of CAR-T cells." This patent discloses compositions and methods for treating liver metastases in a subject. The methods include hepatic arterial infusion (HAI) of chimeric antigen receptor modified T cells (CAR-T), which are specifically designed to target tumor antigens such as carcinoembryonic antigen (CEA). The HAI method is optimized to maximize the exposure of the modified cells to metastatic cells while minimizing exposure to healthy cells. Additionally, the methods include the co-administration of a second therapeutic agent, such as IL-2.

Another significant patent is "Compositions and methods for treating peritoneal cancers." This disclosure provides compositions and methods for treating peritoneal cancer in a subject. The methods involve administering a T cell that is genetically modified to express a chimeric T cell receptor protein. This protein may include a T cell receptor signaling domain fused to a tumor-associated antigen-binding fragment of an antibody or a naturally occurring ligand that specifically binds to a tumor cell surface protein. The disclosed methods are therapeutically effective in reducing tumor burden, abdominal ascites, peritoneal mucin, or serum tumor marker levels.

Career Highlights

Steven has worked with several organizations, including Prospect CharterCare RWMC, LLC. His experience in these companies has contributed to his expertise in the field of medical innovations.

Collaborations

Throughout his career, Steven has collaborated with notable individuals such as Richard P Junghans and Antony Bais. These collaborations have likely enhanced his research and development efforts.

Conclusion

Steven C Katz is a prominent inventor whose work in cancer treatment through innovative methods has the potential to significantly impact patient care. His patents reflect a commitment to advancing medical technology and improving therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…